Barrett's metaplasia

Lancet

Volumn 356, Issue 9247, 2000, Pages 2079-2085

  Jankowski, Janusz A ^a,c   Harrison, Rebecca F ^a   Perry, Ian ^a   Balkwill, Fran ^b   Tselepis, Chris ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Histopathology Laboratory

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; BILE ACID SYNTHESIS; CANCER PREVENTION; CANCER STAGING; CARCINOGENESIS; CONFERENCE PAPER; CYTOKINE PRODUCTION; ESOPHAGUS CARCINOMA; HEALTH SURVEY; HUMAN; PRECANCER; PRIORITY JOURNAL;

EID: 0034676755     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03411-5     Document Type: Conference Paper

References (67)

1. Prevalence of columnar-lined (Barrett's) Oesophagus
2. Carcinoma arising in familial Barrett's esophagus
3. The rising trend on oesophageal adenocarcinoma and gastric cardia
4. Gastro-oesophageal cancer: Death at the junction
5. Barrett's esophagus: It's prevalence and association with adenocarcinoma in patients with symptoms of gastroesphageal reflux
6. Barrett's esophagus: Age, prevalence and extent of columnar epithelium
7. Risk factors for the development of an adenocarcinoma in Barrett's oesophagus
8. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
9. Barrett's esophagus: Comparison of benign and malignant cases
10. Association between body mass and adenocarcinoma of the esophagus and gastric cardia
11. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma
12. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma
13. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma
14. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus
15. The prevalence of Barrett's esophagus in patients with chronic peptic esophageal strictures
16. Barrett's esophagus: An update on screening, surveillance and treatment
17. Molecular evolution of the metaplasia dysplasia adenocarcinoma sequence in the esophagus (MCS)
18. Columnar and metaplastic cells in vault smears
19. Extension of squamous epithelium into the proximal stomach: A newly recognised mucosal abnormality
20. The esophageal Z-line appearance correlates to the prevalence of intestinal metaplasia
21. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma
22. Field cancerization, clonality and epithelial stem cells: The spread of mutated clones in epithelial sheets
23. Clonal analysis of isolated intestinal metaplastic glands of the stomach using X linked polymorphism
24. The demonstration of tissue clonality by X-linked enzyme histochemistry
25. Evolution of neoplastic cell lineages in Barrett's esophagus
26. The role of gastric carditis in metaplasia and neoplasia at the gastro-oesophageal junction
27. Clonal origin of bladder cancer
28. Gut instincts: Thoughts on intestinal epithelial stem cells
29. Barrett's esophagus in three children after antileukemia chemotherapy
30. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue
31. Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog
32. Differentation and proliferation in Barrett's esophagus and the effects of acid suppression
33. Duodeno-gastric reflux: Relationship to pH and importance in Barrett's esophagus
34. Proton pump inhibitors for Barrett's oesophagus
35. GERD, DGER, or both in Barrett's esophagus?
36. Reduced bile acid induced apoptosis in 'normal' colorectal mucosa: A potential biological marker for cancer risk
37. Increased expression of EGFR in Barrett's esophagus associated with alkaline reflux: A putative model for carcinogenesis
38. Implication of duodenogastric reflux in the pathogensis of Barrett's oesophagus
39. Endogenous secondary bile acid levels modify epithelial biology in Barrett's oesophagus
40. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
41. Mucosa-associated lymphoid tissue (MALT) in Barrett's esophagus; prospective evaluation and association with gastric MALT, MALT lymphoma and Helicobacter pylori
42. Inflammation and intestinal metaplasia of the gastric cardia: The role of gastroesophageal reflux and H pylori infection
43. The histopathology of treated Barrett's esophagus: Squamous reepithelialization after acid suppression and laser and photodynamic therapy
44. Barrett's metaplasia: Remodelling by the microenvironment
45. Atrophy and intestinal metaplasia one year after cure of H pylori infection: A prospective, randomised study
46. Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus
47. Pancreatic metaplasia in different disease states and the association with inflammation
48. Expression of interleukin 8 and substance P in human chronic pancreatitis
49. Pouchitis
50. Patterns of inflammation linked to ulcer disease
51. Diversion colitis in children: An iatrogenic appendix vermiformis?
52. Endoscopic observation of squamous metaplasia of the stomach: A report of two cases
53. Metaplastic polyp of the colon develops in response to inflammation
54. Complete and incomplete intestinal metaplasia at the oesophagogastric junction: Prevalences and associations with endoscopic erosive esophagitis and gastritis
55. Agarose plug instillation causes goblet cell metaplasia by activating EGF receptors in rat airways
56. Role of T helper 2 cells in intestinal goblet cell hyperplasia in mice infected with trichinella spiralis
57. Superoxide anions produced by inflammatory cells play an important part in the pathogenesis of acid and pepsin induced oesophagitis in rabbits
58. Role of caspases and NF-kappaB signaling in hydrogen peroxide and superoxide induced hepatocyte apoptosis
59. Overexpression of Fas ligand during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus
60. Secreted and membrane associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors
61. Conversion of TNF alpha from antiproliferative to proliferative ligand in mouse intestinal epithelial cells by regulating mitogen-activated protein kinase
62. Mice deficient in tumor necrosis factor alpha are resistant to skin carcinogenesis
63. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
64. Germ-line E-cadherin gene (CDH1) mutations predispose to familial gastric and colorectal cancer
65. Altered cadherin/catenin complexes in the dysplasia-adenocarcinoma sequence: Correlation with disease progression and de differentiation
66. Regulation of LEF-1/TCF transcription factors by Wnt and other signals
67. TNF-α induces elevated levels of nuclear TCF/β-catenin complexes in a colon carcinoma cell line